Captrust Financial Advisors 10x Genomics, Inc. Transaction History

Captrust Financial Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $154,028 - $258,284	4,488 New	4,488 $251,000
Q2 2022 Aug 23, 2022	SELL	$36.95 - $82.41 $44,968 - $100,292	-1,217 Reduced 83.99%	232 $10,000
Q2 2022 Aug 16, 2022	SELL	$36.95 - $82.41 $6,909 - $15,410	-187 Reduced 11.43%	1,449 $66,000
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $67,786 - $177,426	1,217 Added 290.45%	1,636 $124,000
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $20,257 - $27,388	-150 Reduced 26.36%	419 $62,000
Q3 2021 Nov 16, 2021	SELL	$145.58 - $192.14 $3,639 - $4,803	-25 Reduced 4.21%	569 $83,000
Q2 2021 Aug 16, 2021	SELL	$134.22 - $202.37 $5,503 - $8,297	-41 Reduced 6.46%	594 $116,000
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $61,008 - $85,634	435 Added 217.5%	635 $115,000
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $11,678 - $17,862	200 New	200 $18,000

285

95.8M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.